The methods used to diagnose Helicobacter pylori infection were extensively evaluated 10-15 years ago [1] [2] [3] [4] [5] . Since then, new developments, such as fecal tests [6] [7] [8] , have appeared. Although first-generation polyclonal tests have been shown to be largely unreliable, new monoclonal tests achieve far better results [9] . Sub-C-urea breath test (UBT), is now marketed for use with a new nondispersive, isotope-selective infrared spectroscope (NDIRS). These devices have been shown to be as reliable as isotope ratio mass spectrometers (IRMS) but are far smaller and cheaper, and they allow for in-office, near-immediate reading of results [10] [11] [12] . Some of the kits marketed in Europe for this tool, however, use a shorter time for reading than has previously been recommended (20 min, instead of 30 min) [13, 14] . In addition, unlike the kits marketed by Otsuka in the United States [15] , the European kits do not include coadministration of citric acid, which is a measure that has been shown to increase the UBT's sensitivity and to reduce "gray area" results [16, 17] . Validation studies to establish the cutoff value for this test were performed in Japan [18] [19] [20] [21] but, to our knowledge, have not been reproduced in other settings.
No face-to-face comparison of these new or modified diagnostic methods has been performed to date. A reappraisal of the diagnostic tests for H. pylori infection seems to be warranted. The objective of the present study was to evaluate the effectiveness of current devices for diagnosing H. pylori infection in dyspeptic patients in a large-scale trial.
PATIENTS AND METHODS
Outpatients sent to the Endoscopy Unit of the Hospital de Sabadell (Barcelona, Spain) for dyspeptic symptoms from February 2006 through January 2008 were prospectively recruited for the study. Patients were contacted before the endoscopic examination and were asked to participate in the study. Those who agreed were instructed to avoid antisecretory drugs in the 2 weeks before the endoscopic examination. Patients who were unable to stop antisecretory drugs, those who had received antibiotics in the 4 weeks before the endoscopic examination, and those with previous treatment for H. pylori infection were excluded. Patients were asked to bring a fecal sample on the day that the endoscopic examination was to be performed. Before the endoscopic examination, the patient signed an informed consent form, and a UBT was administered. During endoscopic examination, 2 antral biopsy samples for histological examination and 1 antral biopsy sample for urease testing were obtained. Two hundred nine patients were included in the study. Ten of these patients were excluded, because either UBT test results, fecal samples, or histological examination findings were unavailable, for a variety of technical reasons. The remaining 199 patients were available for analysis. Patients' clinical and demographic data are shown in table 1.
Diagnostic Tests
Sample collection and analysis. Fresh fecal samples were collected, aliquoted, and stored at Ϫ80ЊC until analysis. The tests (histological examination, rapid urease test [RUT] , UBT, and the stool test) were performed by different operators who were unaware of the results of the other assessments.
Fecal test. Amplified IDEIA Hp StAR (Thermo Fisher Scientific), which is a monoclonal enzyme immunoassay, was used for the study. This stool test has shown the best diagnostic performance in previous evaluations [9, [22] [23] [24] [25] [26] [27] . The test was conducted in accordance with the manufacturer's specifications, with dual wave length readings. Samples with absorbances 10.150 were considered to be positive.
UBT. UBT was performed using UBiT 100 mg (Otsuka Pharmaceutical Europe). Determinations were performed in accordance with the manufacturer's specifications. A basal breath sample was collected by blowing into a specifically designed bag. After this, patients drank a solution of 100 mg of 13 C-labelled urea in 100 mL of water, washed their mouth out with water, and 20 min later, filled a second breath bag. Samples were immediately processed by NDIRS (POCone Infrared Spectrophotometer; Otsuka Pharmaceutical). In accordance with the manufacturer's specifications, an increase in the 13 C: 12 C ratio (delta 13 CO 2 ) of у2.5% after urea intake was considered to be indicative of H. pylori infection.
Given that the 2.5% cutoff value generated an unexpected rate of false-positive results, 2 post hoc analyses were performed. First, to evaluate the performance of infrared spectroscopic examination, 120 additional patients who underwent a routine UBT with 13 C urea plus citric acid in accordance with the current standard European protocol (Tau-Kit; ISomed) [16] had duplicate samples collected that were evaluated by both IRMS and NDIRS. Because the correlation of readings was near perfect (see Results), a post hoc statistical analysis was performed with the data for the 199 patients from the original study to establish the optimal cutoff value for the UBT. Final sensitivities and specificities of the different diagnostic techniques were calculated according to the modified cutoff value for this UBT.
RUT and histological analysis. RUT was performed after mucosal samples were obtained with the JATROX HP test (CHR Heim Arzneimittel) and results were read according to the manufacturer's specifications. Samples with negative urease test results were routinely incubated overnight at 37ЊC. However, none of the samples with initial negative RUT results had subsequent positive results. Biopsy samples for histological examination were collected in formalin, stained with Giemsa, and evaluated by 2 pathologists who specialized in digestive diseases. The pathologists were blinded to the results of the other diagnostic tests. 
Statistical Methods
Sample size calculation. Assuming a prevalence of H. pylori infection of 75% in the population with dyspepsia that was evaluated [28, 29] , a sample size of 203 patients was necessary to obtain an estimation of sensitivity with a 95% confidence interval of 0.05 and a confidence level of 0.9.
Statistical analysis. H. pylori infection status was determined on the basis of the combined results of the RUT, histological examination, UBT, and fecal tests. Patients with у2 positive test results were considered to be infected. Sensitivity, specificity, and positive and negative predictive values were calculated for each diagnostic technique and expressed as percentages and 95% confidence intervals. Given the unexpectedly high rate of false-positive UBT results obtained when using the cutoff value provided by the manufacturer, a post hoc evaluation was performed: a receiver operating characteristic curve was drawn to determine the cutoff value that demonstrated the best sensitivity and specificity. Linear correlation was used to compare values of the readings from NDIRS and IRMS, and mean values were compared by Student's t test. The McNemar test was used to compare the sensitivity and specificity of the different tests [30] . To correct for multiple comparisons, only P values of р.01 were considered to be significant. Quantitative variables are given as mean values ‫ע‬ standard deviations. All calculations were performed using SPSS, version 15.0 for Windows (SPSS). The study was performed in compliance with the Standards for the Reporting of Diagnostic Accuracy Studies (STARD) recommendations [31] .
RESULTS
Among 199 patients, 107 (54%) had positive RUT results, 107 (54%) had positive histopathological findings, 108 (54%) had positive stool test results, and 149 (75%) had positive UBT results. In accordance with the preestablished gold standard, 118 patients (59%) with у2 positive test results were considered to be infected. With use of the recommended delta value of 2.5%, the UBT had a sensitivity of 99.2% but a specificity of only 60.5%, with 32 false-positive results. Most of these falsepositive results were in a "gray area" of delta values, between 2.5% and 12%, with a median value of 5.4% and an interquartile range of ‫%7.4ע‬ (figure 1). In this initial analysis, the sensitivities and specificities of the remaining tests were 91% and 100%, respectively, for histological analysis; 91% and 100%, respectively, for RUT; and 90% and 98%, respectively, for the stool test. No statistically significant differences were observed between tests, except for the UBT, which demonstrated statistically significantly less specificity than the other 3 tests (P ! , by McNemar test). Figure 2 shows a STARD flow diagram .01 for calculations performed with the manufacturer's recommended cutoff for UBT.
Recalculating a cutoff value for UBT. To evaluate whether the high rate of false-positive results was attributable to the infrared reading device, dual readings by means of IRMS and NDIRS were performed for 120 additional patients. Comparison of the IRMS and NDIRS showed a near perfect correlation ( In addition, because UBT is a quantitative variable, we evaluated whether the analysis of the delta values could increase the test's reliability. Most false-positive test results in this series still had a range of delta values that were near the cutoff value, between 8.5% and 12%. Therefore, the high-positive results of the UBT were very reliable: UBT with delta values 112% had a specificity of 196% and a near-100% positive predictive value for H. pylori infection. The McNemar test found no statistically significant differences: there was a trend for the 2 noninvasive tests to be less sensitive and specific than the RUT and histological examination, but the differences did not reach statistical significance when using the preestablished cutoff value of . P ! .01 A final point investigated was the usefulness of combined RUT and histological examination. The combination was shown to be extremely reliable, with a sensitivity of 97% and a specificity of 99% for diagnosing H. pylori infection.
DISCUSSION
The most striking finding of the study was the unexpectedly low reliability of UBT. If adequately performed, UBT has been shown to be as reliable as histological examination. The poor performance of the test in our series may be attributable to 2 main reasons. First, the low cutoff value was established in a series of only a few individuals and, to our knowledge, has not been retested: there are no published validations of this particular kit in the medical literature outside of Japan and, indeed, very few there [18] [19] [20] [21] . In the package insert of the test approved by the US Food and Drug Administration, data are reported for 499 duodenal ulcer patients [15] . Although the specificity of the test was 89% with use of a delta cutoff value of 2.4%, specificity was calculated on the basis of data from only 30 patients with H. pylori-negative duodenal ulcers. Therefore, the data on the adequacy of the cutoff value established for Otsuka's Breathtek and Meretek UBT kits commercialized in the United States are also limited. In addition, both the test (which includes the preadministration of citric acid) and the population (patients with duodenal ulcers instead of patients with uninvestigated dyspepsia) differed from those in the present study.
In our study, establishing a new, higher cutoff value for the test considerably improved the reliability of the technique, although sensitivity and specificity both remained ∼90%, which are relatively low values for UBT. This may be related to the second important point: unlike the kits marketed by Otsuka in the United States [15] , European kits by this manufacturer do not use concomitant citric acid [13, 14] . Most studies evaluating the need for citric acid in UBT showed higher delta values with citric acid when compared with other test meals or no test meals [16, 17, 32, 33] , although this increase was not statistically significant in some Chinese studies [34] . Citric acid is expected to increase delta values in infected patients and not change delta values in uninfected ones. Adding citric acid may, therefore, well increase the discriminative capacity of the test, reducing the number of patients with "gray area" delta values [17, 33] . However, the improvement is expected to be modest. As our study shows, UBT is a good test even without citric acid, reaching sensitivities and specificities of ∼90%. Citric Table 2 . Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio, and 95% confidence intervals (95% CI) for diagnosis of Helicobacter pylori. acid would probably upgrade the results of the test from good to excellent by improving the discriminative power of UBT in the 5%-15% of patients with borderline delta values [17, 33] . In fact, the studies comparing citric acid versus no test meal or citric acid versus other test meals usually show a slight improvement in UTB accuracy with the use of citric acid. This improvement is rarely statistically significant, because the sample size needed to demonstrate a statistically significant improvement of sensitivity or specificity from 90% to 95% is extremely large, and most of the studies on the topic have been rather small [16, 17, [32] [33] [34] . In addition, adding citric acid to UBT is economical, simple, and safe, thus justifying its generalized use [16, 17, [32] [33] [34] . In fact, the European Standard Protocol includes citric acid with the kit [16] . Taking all of the data into account, our results strongly suggest that the UBT should be modified by including citric acid coadministration to improve its diagnostic accuracy. What did not seem to influence the results of UBT is the method used to read the test. IRMS and NDIRS obtained very similar values when dual readings were performed. This finding is in accordance with other reports in the literature: several noncomparative and comparative studies have demonstrated excellent correlations between IRMS and NDIRS [10, 11, 35] . Differences between IRMS and NDIRS are basically logistical and economic: NDIRS devices are much cheaper, but the reading time is longer, and NDIRS can process only a few breath samples at the same time. NDIRS also requires the connection of large breath bags to the spectrometer for measurement, which makes it more difficult to store and transport large volumes of breath samples to a measuring laboratory. All of these operating characteristics make NDIRS particularly suitable for laboratories in which the daily number of assays performed is not very high or for use as an in-office test [36] .
A final point regarding UBT is that most false-positive test results in this series had a range of delta values of 8.5%-12%, which is near the cutoff for positivity. It should be stressed, therefore, that in addition to being evaluated as positive or negative, UBT results should also be read quantitatively. The study shows that the positive predictive value of delta values 112% is practically 100%. Therefore, a borderline UBT and a strongly positive test result are not the same in terms of confirming the presence of H. pylori infection, a finding which we already observed in previous studies [37] and which should be taken into account in clinical practice.
The present study also shows that biopsy tests continue to be an uncontroversial standard for diagnosing H. pylori infection. Although slightly dependent on the observer and the staining method, biopsy tests achieved sensitivities and specificities 195% [38] . In addition, the combination of RUT and histological examination provided a very high diagnostic yield. The combination of the 2 tests seems sufficient either to confirm or to rule out H. pylori infection in clinical practice, at least for previously untreated patients with uninvestigated dyspepsia, such as those included in the present series.
Regarding the monoclonal enzyme-linked immunosorbent assay Amplified IDEIA Hp StAR test, the results showed that, although it was somewhat less sensitive than histological examination, the test achieved sensitivities and specificities 190%, making it suitable for use in clinical practice. However, this result applies only to this particular kit. The efficacy of stool tests for detecting H. pylori infection depends greatly on the antigen selected for detection. Indeed, it has been shown that polyclonal antibody tests, which have different antigenic compositions depending on the batch used in the test, show very large intratest variability [39] [40] [41] and poor reliability [9, 42] . Overall, the results are far less reliable than those of monoclonal antibody stool tests [9] . In addition, because not all monoclonal antibody tests detect the same antigen, genetic variations of H. pylori strains could lead to geographical variations in diagnostic efficacy. Their usefulness should, therefore, be tested locally. Amplified IDEIA Hp StAR, however, has generally shown good results in the various settings in which it has been evaluated [24] [25] [26] [27] [43] [44] [45] [46] [47] [48] [49] [50] . Finally, the method of detection of the antigen is also important: immunoassays are more reliable than in-office, immunochromatographic tests. Moreover, the quality and reliability of immunochromatographic methods vary widely.
Strengths of this study are that it includes a large sample of ambulatory, unselected dyspeptic patients and that all of the tests were prospectively performed within a short time interval. The sample included is large enough to provide data on the reliability of the different tests with close confidence intervals. The possibility of an error when performing the UBT was also evaluated: the process of collecting the samples and performing the analysis was reviewed jointly with the manufacturers' technicians to rule out an error in obtaining or processing the samples. In addition, we performed a second study to compare the mass spectrometer with the infrared UBT reader and observed a strong correlation between tests, thus suggesting that both the sample collection and the reading of the samples were adequately performed. A limitation of the study is that we could not fully analyze the reasons for the poor performance of the UBT. The likely efficacy of adding citric acid to improve test results should be tested in additional studies.
The use of a post hoc cutoff value for the UBT instead of the manufacturer's established cutoff value could be viewed as a limitation. To avoid this possible drawback, the study clearly separates the data on the accuracy of UBT according to the delta value employed. In addition, the post hoc cutoff calculation was necessary, because it is informative and useful for the reader and gives an indication of the most appropriate cutoff value in clinical practice. The analysis showed that, even with the new cutoff value, the test did not achieve the sensitivity and specificity of 95% that could be expected for the UBT. These findings highlight the need to use citric acid to achieve optimal results with the UBT.
In conclusion, our study shows that histological examination and RUT remain the uncontested gold standard for diagnosing H. pylori infection. Amplified IDEIA Hp StAR can be considered as a noninvasive first-line routine diagnostic test. In contrast, at least some of the IRMS-based UBTs display a low diagnostic efficacy, which may be attributable to recent modifications in the technique. Because the UBiT 100 mg is currently the most frequently used UBT in Spain, and because the kit has been approved by the European Medicaments Agency and is soon to be launched in many other European countries, the findings of the present study must be urgently confirmed or disproved. Use of the test with the current cutoff value could produce a high rate of false-positive results and lead to unnecessary treatment and associated costs. Additional studies are necessary to set a new cutoff value for the test and to evaluate the need for citric acid pretreatment to improve the diagnostic reliability of UBT.
